CliffBio
small molecule

FLUDEOXYGLUCOSE F18

FLUDEOXYGLUCOSE F-18

Loss of exclusivity—loss of exclusivity
CompanyUNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER

Drug detail

Brand nameFLUDEOXYGLUCOSE F18
Active ingredientFLUDEOXYGLUCOSE F-18
Strength20-300mCi/ML
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalAugust 2014
Marketing statusRX

More from UNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FLUDEOXYGLUCOSE F18 patent cliff — loss of exclusivity — | CliffBio